Temporal Changes in Platelet Response in Acute Coronary Syndrome Patients With Prasugrel and Clopidogrel After Stent Implantation-Reference-Cited by-同舟云学术

Temporal Changes in Platelet Response in Acute Coronary Syndrome Patients With Prasugrel and Clopidogrel After Stent Implantation

Published:2018 Issue:2 Volume:82 Page:353-360
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Tello-Montoliu Antonio¹,Rivera José²,Hernández Diana¹,Silvente Ana¹,Jover Eva¹,Rodriguez Ana I¹,Quintana Miriam¹,Romero Ana¹,Orenes-Piñero Esteban¹,Rivera-Caravaca José Miguel¹,Marín Francisco¹,Veliz Andrea¹,Valdés Mariano¹

Affiliation:

1. Cardiology Department, Hospital Clínico Universitario Virgen de la Arrixaca, CIBERCV, IMIB-Arrixaca

2. Centro Regional de Hemodonación, University of Murcia, CIBERER, IMIB-Arrixaca

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/82/2/82_CJ-17-0471/_pdf

Reference30 articles.

1. 1. Authors/Task Force members. Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014; 35: 2541–2619.

2. 2. Tello-Montoliu A, Ueno M, Angiolillo DJ. Antiplatelet drug therapy: Role of pharmacodynamic and genetic testing. Future Cardiol 2011; 7: 381–402.

3. 3. Aradi D, Kirtane A, Bonello L, Gurbel PA, Tantry US, Huber K, et al. Bleeding and stent thrombosis on P2Y12-inhibitors: Collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention. Eur Heart J 2015; 36: 1762–1771.

4. 4. Sibbing D, Steinhubl SR, Schulz S, Schömig A, Kastrati A. Platelet aggregation and its association with stent thrombosis and bleeding in clopidogrel-treated patients: Initial evidence of a therapeutic window. J Am Coll Cardiol 2010; 56: 317–318.

5. 5. Patti G, Pasceri V, Vizzi V, Ricottini E, Di Sciascio G. Usefulness of platelet response to clopidogrel by point-of-care testing to predict bleeding outcomes in patients undergoing percutaneous coronary intervention (from the Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-Bleeding Study). Am J Cardiol 2011; 107: 995–1000.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical significance of high on-treatment platelet reactivity in patients with prolonged clopidogrel therapy;The Korean Journal of Internal Medicine;2021-03-01

2. Is a personalized pharmacotherapeutic approach closed for acute coronary syndrome?;Expert Opinion on Pharmacotherapy;2021-01-31

3. Periprocedural Variability of Platelet Functions in Carotid Artery Stenting: An Analysis Using VerifyNow;Journal of Neuroendovascular Therapy;2021

4. Cost-Effectiveness of Strategies to Personalize the Selection of P2Y12 Inhibitors in Patients with Acute Coronary Syndrome;Cardiovascular Drugs and Therapy;2019-07-31

5. Individual long-term variation of platelet reactivity in patients with dual antiplatelet therapy after myocardial infarction;Platelets;2018-06-05